Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain - PubMed (original) (raw)
Comparative Study
. 2007 Apr;26(1):189-200.
doi: 10.1016/j.nbd.2006.12.010. Epub 2006 Dec 29.
Affiliations
- PMID: 17276692
- DOI: 10.1016/j.nbd.2006.12.010
Comparative Study
Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain
Jeremy M Van Raamsdonk et al. Neurobiol Dis. 2007 Apr.
Abstract
The YAC128 mouse model of Huntington disease (HD) exhibits motor abnormalities, cognitive dysfunction and selective neuropathology which are similar to the human disease. Backcrossing YAC128 mice from the FVB/N strain onto the C57BL/6 strain and the 129 strain revealed that striatal volume loss and motor dysfunction are penetrant on all three genetic backgrounds. The severity of HD-like phenotypes in these mice is modulated by strain and this variation is not accounted for by differences in mutant huntingtin expression. In contrast, nuclear localization of mutant htt is modulated by strain and is correlated with the severity of neuropathology. Differences in phenotypic severity between the strains provide the opportunity to identify modifier genes which could impact the pathogenesis of HD. Importantly, the demonstration of penetrance across all three strains permits examining the effect of specific genes on the phenotypic severity in YAC128 mice without necessarily backcrossing onto the FVB/N strain background.
Similar articles
- Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR. Van Raamsdonk JM, et al. Hum Mol Genet. 2005 Dec 15;14(24):3823-35. doi: 10.1093/hmg/ddi407. Epub 2005 Nov 8. Hum Mol Genet. 2005. PMID: 16278236 - Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM, Pearson J, Murphy Z, Hayden MR, Leavitt BR. Van Raamsdonk JM, et al. BMC Neurosci. 2006 Dec 5;7:80. doi: 10.1186/1471-2202-7-80. BMC Neurosci. 2006. PMID: 17147801 Free PMC article. - Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM, Yang W, Angus S, Sardi PS, Hayden MR, Hung GH, Bennett CF, Cheng SH, Shihabuddin LS. Stanek LM, et al. J Huntingtons Dis. 2013;2(2):217-28. doi: 10.3233/JHD-130057. J Huntingtons Dis. 2013. PMID: 25063516 - Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models.
Graham RK, Slow EJ, Deng Y, Bissada N, Lu G, Pearson J, Shehadeh J, Leavitt BR, Raymond LA, Hayden MR. Graham RK, et al. Neurobiol Dis. 2006 Feb;21(2):444-55. doi: 10.1016/j.nbd.2005.08.007. Epub 2005 Oct 17. Neurobiol Dis. 2006. PMID: 16230019 - Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM, Warby SC, Hayden MR. Van Raamsdonk JM, et al. Brain Res Bull. 2007 Apr 30;72(2-3):124-31. doi: 10.1016/j.brainresbull.2006.10.018. Epub 2006 Nov 16. Brain Res Bull. 2007. PMID: 17352936 Review.
Cited by
- An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.
Cisbani G, Cicchetti F. Cisbani G, et al. Cell Death Dis. 2012 Aug 30;3(8):e382. doi: 10.1038/cddis.2012.121. Cell Death Dis. 2012. PMID: 22932724 Free PMC article. Review. - Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease.
Gidalevitz T, Wang N, Deravaj T, Alexander-Floyd J, Morimoto RI. Gidalevitz T, et al. BMC Biol. 2013 Sep 30;11:100. doi: 10.1186/1741-7007-11-100. BMC Biol. 2013. PMID: 24079614 Free PMC article. - Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease.
Baldo B, Cheong RY, Petersén Å. Baldo B, et al. PLoS One. 2014 Oct 1;9(10):e107691. doi: 10.1371/journal.pone.0107691. eCollection 2014. PLoS One. 2014. PMID: 25271967 Free PMC article. - C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.
Back MK, Kurzawa J, Ruggieri S, von Engelhardt J. Back MK, et al. Int J Mol Sci. 2021 Nov 23;22(23):12664. doi: 10.3390/ijms222312664. Int J Mol Sci. 2021. PMID: 34884469 Free PMC article. - Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.
Pinto RM, Dragileva E, Kirby A, Lloret A, Lopez E, St Claire J, Panigrahi GB, Hou C, Holloway K, Gillis T, Guide JR, Cohen PE, Li GM, Pearson CE, Daly MJ, Wheeler VC. Pinto RM, et al. PLoS Genet. 2013 Oct;9(10):e1003930. doi: 10.1371/journal.pgen.1003930. Epub 2013 Oct 31. PLoS Genet. 2013. PMID: 24204323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases